SE8904296D0 - Transdermal system - Google Patents

Transdermal system

Info

Publication number
SE8904296D0
SE8904296D0 SE8904296A SE8904296A SE8904296D0 SE 8904296 D0 SE8904296 D0 SE 8904296D0 SE 8904296 A SE8904296 A SE 8904296A SE 8904296 A SE8904296 A SE 8904296A SE 8904296 D0 SE8904296 D0 SE 8904296D0
Authority
SE
Sweden
Prior art keywords
transdermal system
active substance
dissociation
controlled
transdermal
Prior art date
Application number
SE8904296A
Other languages
English (en)
Inventor
B Mollgaard
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE8904296A priority Critical patent/SE8904296D0/sv
Publication of SE8904296D0 publication Critical patent/SE8904296D0/sv
Priority to US07/490,088 priority patent/US5120546A/en
Priority to DK91901412.6T priority patent/DK0519926T3/da
Priority to EP91901412A priority patent/EP0519926B1/en
Priority to AT91901412T priority patent/ATE137405T1/de
Priority to PCT/SE1990/000822 priority patent/WO1991009592A1/en
Priority to AU69735/91A priority patent/AU6973591A/en
Priority to JP03501897A priority patent/JP3141110B2/ja
Priority to DE69026837T priority patent/DE69026837T2/de
Priority to ES91901412T priority patent/ES2086529T3/es
Priority to GR960401809T priority patent/GR3020436T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
SE8904296A 1989-12-21 1989-12-21 Transdermal system SE8904296D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8904296A SE8904296D0 (sv) 1989-12-21 1989-12-21 Transdermal system
US07/490,088 US5120546A (en) 1989-12-21 1990-03-07 Transdermal system
ES91901412T ES2086529T3 (es) 1989-12-21 1990-12-12 Sistema transdermico.
AT91901412T ATE137405T1 (de) 1989-12-21 1990-12-12 Transdermales system
EP91901412A EP0519926B1 (en) 1989-12-21 1990-12-12 Transdermal system
DK91901412.6T DK0519926T3 (da) 1989-12-21 1990-12-12 Transdermalt system
PCT/SE1990/000822 WO1991009592A1 (en) 1989-12-21 1990-12-12 Transdermal system
AU69735/91A AU6973591A (en) 1989-12-21 1990-12-12 Transdermal system
JP03501897A JP3141110B2 (ja) 1989-12-21 1990-12-12 経皮システム
DE69026837T DE69026837T2 (de) 1989-12-21 1990-12-12 Transdermales system
GR960401809T GR3020436T3 (en) 1989-12-21 1996-07-02 Transdermal system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8904296A SE8904296D0 (sv) 1989-12-21 1989-12-21 Transdermal system

Publications (1)

Publication Number Publication Date
SE8904296D0 true SE8904296D0 (sv) 1989-12-21

Family

ID=20377820

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8904296A SE8904296D0 (sv) 1989-12-21 1989-12-21 Transdermal system

Country Status (11)

Country Link
US (1) US5120546A (sv)
EP (1) EP0519926B1 (sv)
JP (1) JP3141110B2 (sv)
AT (1) ATE137405T1 (sv)
AU (1) AU6973591A (sv)
DE (1) DE69026837T2 (sv)
DK (1) DK0519926T3 (sv)
ES (1) ES2086529T3 (sv)
GR (1) GR3020436T3 (sv)
SE (1) SE8904296D0 (sv)
WO (1) WO1991009592A1 (sv)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US5512306A (en) * 1992-06-19 1996-04-30 Pharmica Ab Smoking substitute
HU210921B (en) * 1990-03-28 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
WO1993008825A1 (en) * 1991-11-04 1993-05-13 Zymogenetics, Inc. Pdgf gel formulation
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
SE9301171D0 (sv) * 1993-04-07 1993-04-07 Ab Astra Pharmaceutical composition containing lipophilic drugs
US5750140A (en) * 1994-05-20 1998-05-12 Novo Nordisk A/S Transdermal delivery of tiagabine
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
US5733269A (en) * 1996-03-15 1998-03-31 Fuisz Technologies Ltd. Method and kit for positioning transdermal delivery system
IT1283102B1 (it) * 1996-06-06 1998-04-07 Permatec Nv Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
AU5095698A (en) * 1996-10-25 1998-05-15 Copley Pharmaceutical Inc. Transdermal patch
US6022558A (en) * 1997-07-01 2000-02-08 Hu; Oliver Yoa-Pu Transdermal preparations of oxicams
US6630168B1 (en) 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
US6146656A (en) * 1998-01-22 2000-11-14 Nitto Denko Corporation Percutaneous absorption preparation
DE19810951B4 (de) * 1998-03-13 2005-09-29 Ciba Speciality Chemicals Holding Inc. Verwendung eines textilen Materials als transdermales Abgabesystem sowie Verfahren zu seiner Herstellung
AR018321A1 (es) * 1998-03-26 2001-11-14 Alza Corp Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
US6193996B1 (en) 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
WO2000019978A2 (en) * 1998-10-05 2000-04-13 The Penn State Research Foundation Compositions and methods for enhancing receptor-mediated cellular internalization
CZ302035B6 (cs) 1998-12-18 2010-09-15 Alza Corporation Prostredek pro transdermální podání nikotinu
US6248760B1 (en) * 1999-04-14 2001-06-19 Paul C Wilhelmsen Tablet giving rapid release of nicotine for transmucosal administration
WO2000074661A2 (en) * 1999-06-05 2000-12-14 Noven Pharmaceuticals, Inc. Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
US6479467B1 (en) * 1999-12-16 2002-11-12 Eastman Chemical Company Cyclodextrin ethers
DE10003767A1 (de) * 2000-01-28 2001-10-04 Beiersdorf Ag Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung nichtsteroidaler Antirheumatika
EP1300152A1 (en) * 2000-05-31 2003-04-09 Nichiban Company Limited Percutaneous absorption type steroid preparation for external use
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
IT1319665B1 (it) * 2000-11-17 2003-10-23 Pharma Biotech Ltd Addotti di corticosteroidi con polimeri polisaccaridici naturali.
US20030206945A1 (en) * 2000-12-20 2003-11-06 Giulio Tarro Sticking plaster for controlled release of natural interferon
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
US6743254B2 (en) * 2002-02-01 2004-06-01 Mentor Corporation Tissue expander with protection against accidental puncture
DE10212864B4 (de) * 2002-03-22 2005-12-22 Beiersdorf Ag Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung
US20040120995A1 (en) * 2002-04-01 2004-06-24 Martin Debra A Transdermal delivery of pergolide
AU2003231571A1 (en) * 2002-04-30 2003-11-17 Mochida Pharmaceutical Co., Ltd. External preparation enhanced in systemic property of vidarabine
US20030215487A1 (en) * 2002-05-17 2003-11-20 Il Yang Pharm Co., Ltd. Republic Of Korea Matrix-type device for the transdermal delivery of testosterone applied to the non-scrotal skin
US20040077540A1 (en) * 2002-06-28 2004-04-22 Nastech Pharmaceutical Company Inc. Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds
IL152575A (en) * 2002-10-31 2008-12-29 Transpharma Medical Ltd A skin-to-skin transmission system of water-insoluble drugs
DE10304988A1 (de) * 2003-02-07 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit verbessertem Hautklebeverhalten
UA82880C2 (en) * 2003-04-30 2008-05-26 Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
US7323191B2 (en) * 2003-07-28 2008-01-29 Alza Corporation Transdermal warfarin system
JP4160474B2 (ja) * 2003-08-01 2008-10-01 リンテック株式会社 角質改善用積層シート
US7455654B2 (en) * 2003-10-28 2008-11-25 Alza Corporation Method and apparatus for reducing the incidence of tobacco use
DE10357321A1 (de) * 2003-12-05 2005-07-21 Tesa Ag Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung
WO2005089728A2 (en) * 2004-03-19 2005-09-29 Pfizer Health Ab Means for transdermal administration of nicotine
WO2007016419A2 (en) * 2005-07-29 2007-02-08 The General Hospital Corporation Methods and compositions for reducing skin damage
FI118537B (sv) * 2006-03-08 2007-12-14 Kuopion Yliopisto Förfarande för att öka cyklodextrinkomplexering
DE102006019293A1 (de) * 2006-04-21 2007-10-25 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend ein Fentanyl Analogum
US20080156821A1 (en) * 2006-04-25 2008-07-03 Bradley Stuart Galer Topical preparation dispensers and methods of using the same
US20070248656A1 (en) * 2006-04-25 2007-10-25 Galer Bradley S Topical preparation dispensers and methods of using the same
US20070254858A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
US20070254025A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
US8158609B1 (en) 2006-11-02 2012-04-17 Novartis Ag Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
AU2008207104A1 (en) * 2007-01-17 2008-07-24 Devirex Ag Cyclodextrin formulations
DE102007020799A1 (de) 2007-05-03 2008-11-06 Novosis Ag Transdermales therapeutisches System mit Remifentanil
IE20080661A1 (en) * 2008-08-11 2010-03-03 Bk Pharma Systems Ltd Formulations for a two-phase management of wound healing and dressings incorporating such formulations.
ES2438294T3 (es) * 2008-11-11 2014-01-16 Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Complejos de inclusión de pinocembrina con ciclodextrina o sus derivados
EP2504039A4 (en) * 2009-11-25 2014-07-02 Univ Loma Linda Med HEMOSTATIC TEXTILE BASED ON CHITOSAN
TW201206908A (en) * 2010-05-05 2012-02-16 Glaxo Wellcome Mfg Pte Ltd Pharmaceutical compositions and methods of making same
JP5696279B2 (ja) * 2010-12-01 2015-04-08 学校法人自治医科大学 長期徐放型薬剤硬膜外腔留置システム
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
US10653690B1 (en) 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
DE102020111668A1 (de) 2020-04-29 2021-11-04 Organoid Technologies Gmbh Naturstoffpad
EP3962455B1 (en) 2020-05-18 2022-08-31 Orexo AB New pharmaceutical composition for drug delivery

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56123912A (en) * 1980-03-05 1981-09-29 Nitto Electric Ind Co Ltd Drug-containing tape preparation
US4661105A (en) * 1981-06-29 1987-04-28 Alza Corporation Medical bandage for administering vasodilator drug
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4749574A (en) * 1986-04-14 1988-06-07 Fujisawa Pharmaceutical Co., Ltd. Sustained-release transdermal delivery preparations
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
ZA885069B (en) * 1987-07-24 1989-03-29 Fujisawa Pharmaceutical Co Sustained-release percutaneous preparations
US4774329A (en) * 1987-08-04 1988-09-27 American Maize-Products Company Controlled release agent for cetylpyridinium chloride
JPH06253662A (ja) * 1993-02-26 1994-09-13 Iseki & Co Ltd 脱穀装置

Also Published As

Publication number Publication date
DE69026837T2 (de) 1997-01-02
ES2086529T3 (es) 1996-07-01
EP0519926B1 (en) 1996-05-01
AU6973591A (en) 1991-07-24
JP3141110B2 (ja) 2001-03-05
EP0519926A1 (en) 1992-12-30
US5120546A (en) 1992-06-09
DK0519926T3 (da) 1996-06-17
DE69026837D1 (de) 1996-06-05
JPH05504895A (ja) 1993-07-29
WO1991009592A1 (en) 1991-07-11
ATE137405T1 (de) 1996-05-15
GR3020436T3 (en) 1996-10-31

Similar Documents

Publication Publication Date Title
ATE137405T1 (de) Transdermales system
AR241008A1 (es) Procedimiento para el montaje de un ascensor y el ascensor obtenido por el mismo''
NL300007I2 (nl) Preparaat voor de gereguleerde afgifte van een werkzame stof.
PT92838A (pt) Dispensing devices powered by hydrogel
DE68917496T2 (de) Aktivkontrolle des Zwischenraumes.
DE3853420D1 (de) Anrufbearbeitung mit Wechselwirkung.
DE68909691T2 (de) Multischichtkörper zur Abgabe von Duftstoffen.
FI921606A0 (fi) Mikroperoxidas innehaollande hemopeptid som aktiv komponent.
FI941452A (sv) Föreningar, som ökar andra cytotoxiska ämnens antitumöra aktivitet
ES2054962T3 (es) Agentes plaguicidas.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO880348D0 (no) Opprettningsanordning for bilkarosserier.
NO902626D0 (no) Fremgangsmaate for stabilisering av biologisk aktive forbindelser immobilisert paa faste faser.
IT1228673B (it) Dispositivo per la compensazione di tolleranze di posizione.
NO901605L (no) Fremgangsmaate for stabilisering av polyolefiner.
IT216683Z2 (it) Corpo di bobina riutilizzabile.
IT8320600A0 (it) Composizione per un'applicazione topica contenente, come sostanza attiva sull'elasticia', la morbidezza della pelle tiamorfolinone oppure uno dei suoi derivati.
DK376082A (da) Insekticid
IT8820495A0 (it) Procedimento per la preparazione di cumene.
ZA909624B (en) Transdermal system for administering pharmacological compounds under ph-control
NO903111D0 (no) Fremgangsmaate til fremstilling av antiinfeksjonsmidler.
FR2618707B1 (fr) Dispositif de retournement de pieces, notamment de pieces de carrosserie
NO163375C (no) Fremgangsmaate for forbedring av injeksjonsegenskapene tilen vandig heteropolysakkaridopploesning.
IT8422975A0 (it) Dispositivo di scatto ad influenza combinata magnetica passiva microonde attiva, per l'attivazione di mine anticarro o simili.
DE68908663T2 (de) Verfahren zur Konservierung wässriger Systeme mit 1-Methyl-3,5,7-triaza-1-azoniatrizyklodekantrijodid.